Brian Nowosielski

In part 3 of our interview with Megan Smith, PharmD, she discusses the common reasons for hesitancy among patients, specifically for the pneumococcal vaccine.

Laura Mark, PharmD, MHM, FASHP, FABC, and Arpit Mehta, PharmD, MPH, MHA, CPEL, FASHP, discuss the immense role automation has shouldered within pharmacy compounding.

Laura Mark, PharmD, MHM, FASHP, FABC, and Arpit Mehta, PharmD, MPH, MHA, CPEL, FASHP, discuss various roles in centralized IV compounding and robotics.

Megan Smith, PharmD, discusses how pharmacists have taken reigns in boosting pneumococcal vaccine rates across health care.

Annie Lambert, PharmD, BCSCP, discusses compliance solutions and the common gaps existing in the pharmacy compounding industry today.

Lani Bertrand, RPh, discusses Omnicell’s IV compounding solution and how it’s realizing cost savings for pharmacies across the country.

This episode explores the risks necessary for successful pharmacy leaders and the inherent nature of pharmacy that makes the profession risk-averse.

Megan Smith, PharmD, breaks down the public health sector’s current understanding and approach toward pneumococcal vaccines.

Pharmacists enhance asthma care by bridging knowledge gaps, improving medication adherence, and providing cost-effective treatment options for patients.

Exploring the real-time capabilities of chatbots and artificial intelligence (AI), researchers investigate how this technology would impact older adults’ pneumococcal vaccine rates.

This announcement is another move stemming from the federal government's skeptic views on vaccine technology and its efficacy among US patients.

With OTC drug abuse on the rise, particularly among young people, researchers want to better understand ways to prevent it.

Leading health care economist and public policy expert John C. Goodman, PhD, breaks down what various supply chain entities can expect with TrumpRx.

Researchers want to bolster evidence regarding the known link between maternal mental health and childhood nutritional status.

Episode 5 explores insulin management as well as the insulin products, doses, and administration tools all pharmacists should be familiar with for their patients with diabetes.

President Trump signed into law HR 2483, also known as the SUPPORT for Patients and Communities Reauthorization Act of 2025.

In part 3 of our interview with John C. Goodman, PhD, he discusses how TrumpRx could impact the drug supply chain—specifically PBMs.

Researchers explore community-acquired pneumococcal-related hospital admissions among adults from 2000 to 2019 and assess pneumococcal immunization’s impact after the year 2015.

In an exploration of the National Retail Data Monitor, researchers determine how OTC sales contributed to disease surveillance.

John C. Goodman, PhD, discusses TrumpRx’s impact on patients and pharmacies, comparing this administration’s approach with the previous Biden Administration.

John C. Goodman, PhD, senior fellow at the Independent Institute, discusses TrumpRx and its goals for patients’ OOP drug costs.

The agency’s findings spur promises of significant change to the development and recommendations surrounding various immunizations.

Researchers investigate serotype distribution and antimicrobial resistance among children in Mexico with pneumococcal meningitis.

Jeffrey Bratberg, PharmD, BCPS, and Michelle Caetano, PharmD, BCACP, CVDOE, CDOE, BCPT, discuss the Pharmacy Bridge resource and pharmacists’ role in OUD management.

Patient safety organizations began in the early 21st century to improve health care safety measures amongst various providers’ practices.

Researchers conduct a cost-effectiveness analysis to uncover the public health and economic impacts of PCV20 among Australian children.

In this episode, host Taylor Watterson, PharmD, PhD, welcomes Wesley Sparkmon, PhD, MPH, assistant professor of pharmacy sciences at Creighton University.

Novo Nordisk announced results of the evoke and evoke+ phase 3 trials on semaglutide’s use in treating Alzheimer disease progression.

Catie Stimmel, PharmD, discusses the pharmacist’s role in ensuring PSOs operate at their intended capabilities.

Catie Stimmel, PharmD, explores the confidentiality and non-punitive processes that are crucial in driving value toward patient safety organizations.